Walgreens Earnings: What To Look For From WBA

StockStory
04-07
Walgreens Earnings: What To Look For From WBA

Pharmacy chain Walgreens Boots Alliance (NASDAQ:WBA) will be reporting results tomorrow before market open. Here’s what to look for.

Walgreens beat analysts’ revenue expectations by 5.7% last quarter, reporting revenues of $39.46 billion, up 7.5% year on year. It was a stunning quarter for the company, with a solid beat of analysts’ EPS estimates and an impressive beat of analysts’ EBITDA estimates.

Is Walgreens a buy or sell going into earnings? Read our full analysis here, it’s free.

This quarter, analysts are expecting Walgreens’s revenue to grow 1.9% year on year to $37.76 billion, slowing from the 6.3% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.52 per share.

Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Walgreens has a history of exceeding Wall Street’s expectations, beating revenue estimates every single time over the past two years by 3.7% on average.

Looking at Walgreens’s peers in the consumer retail segment, some have already reported their Q1 results, giving us a hint as to what we can expect. Costco delivered year-on-year revenue growth of 9%, beating analysts’ expectations by 1.1%, and AutoZone reported revenues up 2.4%, falling short of estimates by 0.8%. Costco traded down 6.2% following the results while AutoZone was up 2.6%.

Read our full analysis of Costco’s results here and AutoZone’s results here.

Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we’ve identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10